An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization
Transplant Infectious Disease · 2023
DOI: 10.1111/tid.13951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Waseem Amjad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Investigation, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections. Die Arbeit nennt 27 Literaturangaben. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Background
Organ transplantation is a known risk factor for Clostridioides difficile infection (CDI). There is limited published data on the impact of CDI in the intestinal transplant population.
Methods
We utilized the National Readmission Database (2010–2017) to study the outcomes of CDI in patients having a history of intestinal transplantation. Association of CDI with readmission and hospital resource utilization was computed in multivariable models adjusted for demographics and comorbidities.
Results
During 2010–2017, 8442 hospitalizations with the history of intestinal transplantation had indexed hospital admissions. Of these, 320 (3.8%) had CDI. CDI hospitalization in intestine transplant patients was associated with higher median cost $54 430 (IQR: 27 231, 109 980) as compared to patients who did not have CDI $48 888 (IQR: 22 578, 112 777), ( β : 71 814 95% confidence intervals [CI]: 676–142 953, p = .048). The median length of stay was also longer for patients with CDI 7 (IQR: 4, 13) days as compared to 5 (IQR: 3, 11) days in non‐CDI ( β : 5.51 95% CI: 0.73–10.29, p = .02). The mortality rate, intestinal transplant complications, presence of malnutrition, acute kidney injury, ICU admissions, and sepsis were similar in both groups. CDI was the top cause of 30‐day readmission in the intestinal transplant recipients with CDI during the index admission; the number of 30‐day readmissions also increased from 2010 to 2017.
Conclusion
CDI hospitalization in post–intestine transplant patients occurs commonly and is associated with a longer length of stay and higher costs during hospitalization. The CDI was the most common cause of readmission after the index admission of CDI in these patients. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Investigation, Harvard Medical School, Boston, Massachusetts, USA.
- Research fellow, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Recanati-Miller Transplantation Institute, Mount Sinai Medical Center, New York, New York, USA.
- Gastroenterology and Liver Transplant, Duke University School of Medicine, Durham, North Carolina, USA.
- Internal Medicine, Loyola School of Medicine, Chicago, Illinois, USA.
- Abdominal Organ Transplant, New York Presbyterian Hospital-Columbia University Irving Medical Center, New York, New York, USA.
ORCID-Profile: Waseem Amjad
Förderung
- NIAID NIH HHS
Zitieren
APA
Amjad, W., Schiano, T., Segovia, M. C., Malik, A., Weiner, J., Horslen, S., & Jafri, S. M. (2023). An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization. Transplant Infectious Disease. https://doi.org/10.1111/tid.13951
Vancouver
Amjad W, Schiano T, Segovia MC, Malik A, Weiner J, Horslen S, et al. An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization. Transplant Infectious Disease. 2023. doi:10.1111/tid.13951
BibTeX
@article{Amjad2023,
author = {Amjad, Waseem and Schiano, Thomas and Segovia, Maria C and Malik, Adnan and Weiner, Joshua and Horslen, Simon and Jafri, Syed-Mohammed},
title = {An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization},
journal = {Transplant Infectious Disease},
year = {2023},
doi = {10.1111/tid.13951}
}
EUVIMED